250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care VC (Venture Capital) Funds in Finland in May 2025

A list of 50 VC (Venture Capital) funds that invest in Health care startups based in Finland. We rank investors based on the number of investments they made in Health care companies from Finland. We update this investor list every month.

Top 50 Health Care VC (Venture Capital) Funds in Finland in May 2025

Investor Health Care Finland investments
Butterfly Ventures 18
Lifeline Ventures 17
Tesi 15
Finnvera Venture Capital 15
Business Finland 14
Voima Ventures 13
Innovestor 11
Icebreaker.vc 11
Inventure 7
Reaktor Ventures 6
Springvest 6
Redstone.VC 6
Visionplus 5
VTT Ventures 4
Maki.vc 4
Nidoco 4
Oy Hammaren & Co Ab 4
Cor Group 3
Athensmed 3
Sitra 3
M Ventures 3
First Fellow Partners 3
Pontos Group 2
Metsola Ventures 2
Lynx Capital 2
Vesalius Biocapital Partners 2
Almaral 2
University of Helsinki 2
Samsung Venture Investment 2
Korpun Siemen 2
Nina Capital 2
HealthCap 2
Capricorn Partners 2
Novartis Venture Fund 2
Nostetta Ventures 2
Heraeus 2
Stephen Industries 2
Karolinska 2
Broadview Ventures 2
Gorilla Capital 2
Novo Holdings 2
Superhero Capital 2
Sofinnova Partners 2
Nordic Science Investments 2
EQT Life Sciences 2
Conor Venture Partners 2
European Investment Bank 2
K5 Global 1
IPF Partners 1
Midinvest Management 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Butterfly Ventures VC Fund · Oulu, Oulu, Finland · 4 investments in the past 12 months
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Finland, Sweden, Norway
Portfolio highlights
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Hypertype — Smartest email experience ever made.
  • Happy Plant Protein — Changing the way plant proteins are made
Lifeline Ventures VC Fund · Helsinki, Southern Finland, Finland · 10 investments in the past 12 months
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • Bought — A fully automated secondhand marketplace unleashing the 95% of hidden secondhand supply with AI.
  • Soldera — Soldera enables renewable energy producers to earn additional income through an automatic guarantee of the origin trading system.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Tesi VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more
Investment focus
  • Software, Manufacturing, Health Care
  • Funding Round, Series A, Series B
  • Finland, United States, Argentina
Portfolio highlights
  • Seaber — Seaber is a cloud-based real-time planning, optimisation and communication solution for bulk cargo & vessels. Our solution improves the efficiency of bulk & break bulk charterers, shipowners & brokers through schedule planning and stakeholder communications over the lifecycle of a voyage.
  • TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Finnvera Venture Capital VC Fund · Kuopio, Eastern Finland, Finland · 2 investments in the past 12 months
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Finland, United States, Switzerland
Portfolio highlights
  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Business Finland VC Fund · Helsinki, Southern Finland, Finland · 19 investments in the past 12 months
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Grant, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
  • SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Individuals and Small Businesses. Create your free account now!
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Voima Ventures VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Seed, Pre-Seed, Funding Round
  • Finland, Sweden, Norway
Portfolio highlights
  • Skyfora — Skyfora combines scientific understanding of tropical storms with computer vision, machine learning and IoT technologies.
  • StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
  • Liquid Sun — Liquid Sun Ltd. We fight against climate change by recoding CO2 emissions to fossil-free fuels and chemicals. Our technology is based low temperature electrolyzers.
Innovestor VC Fund · Helsinki, Southern Finland, Finland · 11 investments in the past 12 months
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
  • Software, Health Care, Manufacturing
  • Seed, Funding Round, Series A
  • Finland, Denmark, Sweden
Portfolio highlights
  • Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
  • Bahn Express — Fast and Effortless Car Transport
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Icebreaker.vc VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Finland, Sweden, Estonia
Portfolio highlights
  • Grid Raven — Maximize the safety and capacity of your grid with accurate ratings based on our hyper-local weather model that accounts with every tree, building and hill.
  • Clock & Cloud — AI-driven platform delivering actionable geopolitical intelligence for proactive decision-making and enhanced business security
  • Fleetbrains — At Fleetbrains, we transform fleet sales and stock management with cutting-edge AI, enabling dealerships and manufacturers to optimize stock, maximize margins, and accelerate vehicle turnover.Our intelligent platform leverages Big Data, Machine Learning, and Large Language Models to predict demand, streamline inventory management, and enhancebusiness decision-making. By redefining traditional sales and forecasting models, we help automotive businesses minimize stock leftovers, improve purchasing strategies, and drive higher profitability.Join us in shaping the future of automotive sales with AI-powered intelligence.
Inventure VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • Finland, Sweden, Denmark
Portfolio highlights
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
  • Biomatter — Biomatter Designs is pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
  • Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Reaktor Ventures VC Fund · Helsinki, Southern Finland, Finland
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more
Investment focus
  • Software, Internet, Health Care
  • Seed, Pre-Seed, Series A
  • Finland, Germany, United States
Portfolio highlights
  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
  • Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Springvest VC Fund · Helsinki, Southern Finland, Finland
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Series A, Funding Round, Seed
  • Finland
Portfolio highlights
  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Redstone.VC VC Fund · Berlin, Berlin, Germany · 11 investments in the past 12 months
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, Finland, France
Portfolio highlights
  • Aslan — Aslan a platform or solution designed to enhance employee benefits by offering more customizable and flexible compensation options.
  • Ochy — Ochy is an app that uses AI to analyse running form and gait to identify weak points and provide recommendations on what to do to improve.
  • Covision Media — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
Visionplus VC Fund · Helsinki, Southern Finland, Finland
WE HELP YOU TO GROW FASTER!
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Funding Round, Series A
  • Finland, United States, United Kingdom
Portfolio highlights
  • Pebble — Pebble is a electric vehicle manufacturing startup.
  • Transfluent — Professional translations for all business needs. Fast. Easy.
  • BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
VTT Ventures VC Fund · Espoo, Southern Finland, Finland
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more
Investment focus
  • Biotechnology, Manufacturing, 3D Technology
  • Seed, Funding Round, Series A
  • Finland
Portfolio highlights
  • Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Maki.vc VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Funding Round
  • Finland, Germany, United Kingdom
Portfolio highlights
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
  • TrackSights — TrackSights combines top-tier data, automated workflows, and actionable insights for the automotive industry. Streamline decisions, calculate values, and manage fleets effortlessly with a modern, easy-to-use interface. Book a demo today!
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Nidoco VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in the past 12 months
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • Finland, Sweden, Estonia
Portfolio highlights
  • Ponta — Connecting brands with real people paying attention.
  • Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
  • TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
Oy Hammaren & Co Ab VC Fund · Finland, Minnesota, United States
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more
Investment focus
  • Health Care, Wellness, GreenTech
  • Funding Round, Angel, Series A
  • Finland
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • Heltti — Heltti redefines occupational healthcare and well-being services with technology and a subscription model. Heltti develops the most lovable digital health care systems. Heltti is a Finnish occupational health care company founded in 2013. It is owned by its employees and a handful of renowned Finnish investors, such as Risto Siilasmaa.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Cor Group VC Fund · Oulu, Oulu, Finland
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Pre-Seed, Series A
  • Finland
Portfolio highlights
  • Gosta Labs — Focus on care
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — The most advanced health check for the health industry.
Athensmed VC Fund
Athensmed Oy
Show more
Investment focus
  • Health Care, Medical, mHealth
  • Seed, Series A, Funding Round
  • Finland
Portfolio highlights
  • VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Sitra VC Fund · Helsinki, Southern Finland, Finland
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more
Investment focus
  • Health Care, Biotechnology, Therapeutics
  • Funding Round, Series A, Series C
  • Finland, The Netherlands
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • SET Ventures — Europe's leading energy VC since 2007. Backing the continent's most innovative energy entrepreneurs with capital, community and insights
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 16 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • IonKraft — IonKraft can provide better performance at a lower cost while maintaining recyclability, they also promote material reduction and reuse and are commercializing the technology with funding from the German Federal Ministry for Economic Affairs and Energy (BMWi).
  • NovoLINC — NovoLINC is a pioneering startup that provides thermal interface solutions. It develops a distinctive system of nanostructured materials and a proprietary manufacturing process with the objective of transforming thermal management.
  • TRIMTECH Therapeutics — TRIMTECH Therapeutics is a biotech organization that treats neurodegenerative illnesses by using targeted protein degradation (TPD).
First Fellow Partners VC Fund · Helsinki, Southern Finland, Finland
A private investment firm run by Risto Siilasmaa and Kim Groop. Grounded in a deeply held set of values around entrepreneurship, trust, integrity and helping solve the world’s problems. We partner with strong and ambitious technology entrepreneurs driven by a mission to fix or build something important in the world.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • Finland, United States, Estonia
Portfolio highlights
  • LumiDB — Transform terabytes of accumulated scans into a queryable database that you can actually use.
  • Vuo AI — Building blocks for advanced AI-based applications
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Pontos Group VC Fund · Helsinki, Southern Finland, Finland
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more
Investment focus
  • Genetics, Hospital, Automotive
  • Funding Round
  • Finland
Portfolio highlights
  • Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Metsola Ventures VC Fund · Espoo, Southern Finland, Finland
Metsola Ventures
Show more
Investment focus
  • Medical, mHealth, Health Care
  • Series A
  • Finland
Portfolio highlights
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Lynx Capital VC Fund · Shanghai, Shanghai, China
cross-border, healthcare, life science, investment, VC, China, US
Show more
Investment focus
  • Therapeutics, Biotechnology, Pharmaceutical
  • Series A
  • Finland
Portfolio highlights
  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Vesalius Biocapital Partners VC Fund · Strassen, Luxembourg, Luxembourg · 5 investments in the past 12 months
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Almaral VC Fund · Kaarina, Western Finland, Finland
Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
Show more
Investment focus
  • Software, Education, E-Learning
  • Seed, Funding Round
  • Finland
Portfolio highlights
  • Seppo — Seppo is an online programme for creating educational games. It can be used on all levels from pre-school to university.
  • Marginum — Pioneering the next-generation quantitative surgical techniques.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
University of Helsinki VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more
Investment focus
  • Apps, Hospital, Consulting
  • Seed, Grant, Pre-Seed
  • Finland, Luxembourg
Portfolio highlights
  • NADMED — The standard of NAD measuring
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Samsung Venture Investment VC Fund · Seocho, Seoul-t'ukpyolsi, South Korea · 9 investments in the past 12 months
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Series A, Series B, Seed
  • South Korea, United States, India
Portfolio highlights
  • wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
  • Medisolar — Medisol is a food technology firm that also provides personalized food care solutions.
  • C2N Diagnostics — C2N Diagnostics, LLC is a privately held protein diagnostic and therapeutic discovery company targeting progressive neurodegeneration. They formed in late 2007 by scientific co-founders Drs. David Holtzman and Randall Bateman of Washington University School of Medicine in St. Louis, and LifeTech Research, a Maryland-based technology research andcommercialization firm (www.lifetechresearch.com). They reside at the Center for Emerging Technologies in St. Louis.
Korpun Siemen VC Fund · Oulu, Oulu, Finland · 2 investments in the past 12 months
Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more
Investment focus
  • Software, Information Technology, Pet
  • Seed, Funding Round, Angel
  • Finland
Portfolio highlights
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
  • Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 10 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Germany
Portfolio highlights
  • CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
  • Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
  • MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 6 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Capricorn Partners VC Fund · Leuven, Vlaams-Brabant, Belgium · 5 investments in the past 12 months
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands
Portfolio highlights
  • InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
  • Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
  • Econic Technologies — At Econic, we are pioneering the transformation of CO2 into high-performance materials that shape a better future for all.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 11 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
  • Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Nostetta Ventures VC Fund · Kuopio, Eastern Finland, Finland
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more
Investment focus
  • Health Care, Medical Device
  • Seed, Pre-Seed
  • Finland
Portfolio highlights
  • Marginum — Pioneering the next-generation quantitative surgical techniques.
Heraeus VC Fund · Hanau, Hessen, Germany
Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company.
Show more
Investment focus
  • Manufacturing, Biotechnology, Therapeutics
  • Seed, Corporate Round, Series A
  • Germany, China, Japan
Portfolio highlights
  • CSMH — Compound Semiconductor (Xiamen) Technology Co., Ltd. is an advanced semiconductor manufacturing technology based joint venture company invested from the Korea, China and Singapore, registered in the city of Xiamen, China. We have equipped with advanced semiconductor manufacturing tools including MPCVD, MOCVD, LPCVD, HVPE and high temperature PVDto produce high quality Diamond wafer and AlN template on various substrate including Si, sapphire, and polished diamond. Our mission is to be the most advanced compound semiconductor company in the global market, contributing to the related technology development. We have strong R&D team and actively collaborate with best research group around the world. Currently, we are providing the thermal grade polycrystalline diamond, which can be used as an effective heat sink aims to solve the heat issue in temperature sensitive device, such as power devices, lasers and avalanche photodiodes etc. We also provides wafer scale polished diamond with sub-nanometer RMS surface roughness, which might be suitable for the integration of GaN, GaO and AlN epilayers and devices on Diamond via direct bonding or heteoepitaxy.
  • Holosolis — Holosolis contributes to the EU’s goal of local PV module production and curbing global warming. We will build the largest photovoltaic panel factory in Europe.
  • Tsubame BHB — Tsubame BHB is a Sales company
Stephen Industries VC Fund · Espoo, Southern Finland, Finland · 5 investments in the past 12 months
We fund futurebreakthroughs
Show more
Investment focus
  • Apps, Water, Energy
  • Seed, Funding Round, Series A
  • Finland
Portfolio highlights
  • StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Karolinska VC Fund · Solna, Stockholms Lan, Sweden
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States
Portfolio highlights
  • PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
  • OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Broadview Ventures VC Fund · Boston, Massachusetts, United States · 2 investments in the past 12 months
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Israel, Denmark
Portfolio highlights
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Gorilla Capital VC Fund · 5 investments in the past 12 months
Gorilla Capital invests in early stage Finnish, Swedish, Danish and Estonian technology companies
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden
Portfolio highlights
  • Mjuk — Marketplace for pre-owned, unique design furniture
  • Orijin — A turnkey solution to solve EUDR for coffee & cocoa importers and producers
  • Planmark Oy — Planmark develops an AI-powered reporting platform that streamlines ESG data collection and report generation, allowing companies to focus on core business.
Novo Holdings VC Fund · Hellerup, Hovedstaden, Denmark · 29 investments in the past 12 months
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • United States, Denmark, United Kingdom
Portfolio highlights
  • Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
  • Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
  • Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Superhero Capital VC Fund · Helsinki, Southern Finland, Finland · 10 investments in the past 12 months
Early-stage VC searching for the next Superheroes.
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Pre-Seed, Funding Round
  • Finland, Estonia, Lithuania
Portfolio highlights
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Koll — Koll makes it possible for both individuals and businesses to make phone calls with verified identities. Anonymous calls are a thing of the past.
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 20 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Nordic Science Investments VC Fund · 5 investments in the past 12 months
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more
Investment focus
  • Apps, Food Processing, Food and Beverage
  • Seed
  • Finland
Portfolio highlights
  • Acouspin — Acouspin provides ultrasonic-enhanced, AI-driven seamless technology for efficient and flexible nanofiber production, allowing producers to attain precision without specific expertise.
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Conor Venture Partners VC Fund · Espoo, Southern Finland, Finland
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more
Investment focus
  • Software, Analytics, Semiconductor
  • Series A, Series B, Seed
  • Finland, United States, Sweden
Portfolio highlights
  • TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
  • Blackwood Seven — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
  • Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 25 investments in the past 12 months
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Debt Financing, Post-IPO Debt, Funding Round
  • Germany, France, The Netherlands
Portfolio highlights
  • Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
  • Greenlight Biosciences — Next Generation Crop Protection
  • Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
K5 Global VC Fund · Los Angeles, California, United States · 16 investments in the past 12 months
Backing category-defining companies from inception to IPO.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Brazil
Portfolio highlights
  • Sotira — Make your excess inventory do more for you.
  • Acki Nacki — Acki Nacki is an asynchronous blockchain technology that achieves probabilistic consensus via two communication phases. Acki Nacki is ready to support use cases such as payments, gaming economies, IoT networks, and AI applications.
  • Carbon Arc — Carbon Arc helps decision-makers access high-value data insights through our two-sided exchange. Empower your strategy with decision intelligence.
IPF Partners VC Fund · Luxembourg, Luxembourg, Luxembourg
IPF Partners is a alternative financing provider focused on the European healthcare sector. IPF invests directly in emerging, commercial-stage European pharma/biotech, medtech and diagnostics companies.
Show more
Investment focus
  • Health Care, Medical, Hospital
  • Series B, Series C, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • Lumeon — Transform the patient experience and ensure that care teams always work at top-of-license with the leaders in care orchestration.
  • Mendor — Mendor is a Finnish company, committed to the design, development and marketing of advanced diabetes management products. Mendor has launched a revolutionary, discreet, easy to use, portable all-in-one blood glucose meter and web-based software application for the daily management of diabetes. Mendor has designed its products together with usersand diabetes experts to address the needs of people with diabetes requiring regular blood glucose monitoring.
  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
Midinvest Management VC Fund · Jyväskylä, Western Finland, Finland
Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Funding Round, Convertible Note
  • Finland
Portfolio highlights
  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organization’s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
  • Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Finland by industry